These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11904756)

  • 61. To Stage Alzheimer's Disease Related Neurodegeneration Using one Section of Hippocampus.
    Popova SN; Pesälä S; Alafuzoff I
    J Alzheimers Dis; 2015; 48(3):597-601. PubMed ID: 26402117
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stereological estimates of number and length of capillaries in subdivisions of the human hippocampal region.
    Løkkegaard A; Nyengaard JR; West MJ
    Hippocampus; 2001; 11(6):726-40. PubMed ID: 11811667
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of age and Alzheimer's disease on pyramidal neuron density in the individual fields of the hippocampal formation.
    Davies DC; Horwood N; Isaacs SL; Mann DM
    Acta Neuropathol; 1992; 83(5):510-7. PubMed ID: 1621507
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Duration of neurofibrillary changes in the hippocampal pyramidal neurons.
    Bobinski M; Wegiel J; Tarnawski M; de Leon MJ; Reisberg B; Miller DC; Wisniewski HM
    Brain Res; 1998 Jul; 799(1):156-8. PubMed ID: 9666111
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease.
    Bobinski M; de Leon MJ; Wegiel J; Desanti S; Convit A; Saint Louis LA; Rusinek H; Wisniewski HM
    Neuroscience; 2000; 95(3):721-5. PubMed ID: 10670438
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neuronal RNA in relation to neuronal loss and neurofibrillary pathology in the hippocampus in Alzheimer's disease.
    Hartmann HA
    J Neuropathol Exp Neurol; 1987 Jul; 46(4):507. PubMed ID: 2439658
    [No Abstract]   [Full Text] [Related]  

  • 67. The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer brains.
    Ikonomovic MD; Mizukami K; Davies P; Hamilton R; Sheffield R; Armstrong DM
    J Neuropathol Exp Neurol; 1997 Sep; 56(9):1018-27. PubMed ID: 9291943
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Selective hippocampal neuron loss in dementia with Lewy bodies.
    Harding AJ; Lakay B; Halliday GM
    Ann Neurol; 2002 Jan; 51(1):125-8. PubMed ID: 11782993
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neurofibrillary pathology--correlation with hippocampal formation atrophy in Alzheimer disease.
    Bobinski M; Wegiel J; Wisniewski HM; Tarnawski M; Bobinski M; Reisberg B; De Leon MJ; Miller DC
    Neurobiol Aging; 1996; 17(6):909-19. PubMed ID: 9363803
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neuronal RNA in relation to neuronal loss and neurofibrillary pathology in the hippocampus in Alzheimer's disease.
    Doebler JA; Markesbery WR; Anthony A; Rhoads RE
    J Neuropathol Exp Neurol; 1987 Jan; 46(1):28-39. PubMed ID: 2432192
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neuronal loss in Alzheimer's disease.
    Hyman BT
    Aging (Milano); 1998 Apr; 10(2):156. PubMed ID: 9666209
    [No Abstract]   [Full Text] [Related]  

  • 72. A quantitative histological study of early clinical and preclinical Alzheimer's disease.
    Hubbard BM; Fenton GW; Anderson JM
    Neuropathol Appl Neurobiol; 1990 Apr; 16(2):111-21. PubMed ID: 2345598
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early-stage biomarker discovery.
    Theofilas P; Ehrenberg AJ; Dunlop S; Di Lorenzo Alho AT; Nguy A; Leite REP; Rodriguez RD; Mejia MB; Suemoto CK; Ferretti-Rebustini REL; Polichiso L; Nascimento CF; Seeley WW; Nitrini R; Pasqualucci CA; Jacob Filho W; Rueb U; Neuhaus J; Heinsen H; Grinberg LT
    Alzheimers Dement; 2017 Mar; 13(3):236-246. PubMed ID: 27513978
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relative neuron loss in hippocampal sclerosis of aging and Alzheimer's disease.
    Ihara R; Vincent BD; Baxter MR; Franklin EE; Hassenstab JJ; Xiong C; Morris JC; Cairns NJ
    Ann Neurol; 2018 Nov; 84(5):741-753. PubMed ID: 30246887
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The CA1 region of the human hippocampus is a hot spot in Alzheimer's disease.
    West MJ; Kawas CH; Martin LJ; Troncoso JC
    Ann N Y Acad Sci; 2000 Jun; 908():255-9. PubMed ID: 10911964
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease.
    Bobinski M; de Leon MJ; Tarnawski M; Wegiel J; Reisberg B; Miller DC; Wisniewski HM
    Brain Res; 1998 Sep; 805(1-2):267-9. PubMed ID: 9733982
    [TBL] [Abstract][Full Text] [Related]  

  • 77. No evidence for loss of hippocampal neurons in non-Alzheimer dementia patients.
    Korbo L; Amrein I; Lipp HP; Wolfer D; Regeur L; Oster S; Pakkenberg B
    Acta Neurol Scand; 2004 Feb; 109(2):132-9. PubMed ID: 14705976
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hippocampus of the domestic pig: a stereological study of subdivisional volumes and neuron numbers.
    Holm IE; West MJ
    Hippocampus; 1994 Feb; 4(1):115-25. PubMed ID: 8061750
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Preservation of hippocampal pyramidal cells in paraphrenia.
    Casanova MF
    Schizophr Res; 2003 Jul; 62(1-2):141-6. PubMed ID: 12765754
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modulators of cytoskeletal reorganization in CA1 hippocampal neurons show increased expression in patients at mid-stage Alzheimer's disease.
    Kao PF; Davis DA; Banigan MG; Vanderburg CR; Seshadri S; Delalle I
    PLoS One; 2010 Oct; 5(10):e13337. PubMed ID: 20967212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.